SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy
NCT ID: NCT06282185
Last Updated: 2025-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
20 participants
INTERVENTIONAL
2024-11-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* What is the impact of exercise on quality of life
* What is the impact of exercise on physical fitness
Participants will have an individual training program with supervised training by physiotherapists.
Researchers will compare with usual care to see if advice about exercise has significant less effect than an supervised training program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)
NCT06429813
Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy
NCT02869412
Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate Cancer
NCT06145243
The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.
NCT03675529
Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy
NCT04027270
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
supervised training program for twelve weeks + usual care + advice about exercise
Physiotherapy
supervised training program for twelve weeks + usual care + advice about exercise
usual care
usual care + advice about exercise
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiotherapy
supervised training program for twelve weeks + usual care + advice about exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years old
* Able to read and complete questionnaires in Dutch
* Proven histologically and /or radiologically metastatic prostate cancer (TxNxM1)
Exclusion Criteria
* Clinicians' judgement
* Age \>80 years old or not able to walk 400m
* Structural exercise (moderate-intensity exercise more than 150 minutes a week) during the past 3 months
* Musculoskeletal, cardiovascular, or neurological disorders that could inhibit them from exercising
* Spinal cord compression, history of pathological fractures
18 Years
85 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canisius-Wilhelmina Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Paul van Basten, Dr. MD
Role: PRINCIPAL_INVESTIGATOR
Canisius Wilhelmina Ziekenhuis (CWZ)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Canisius Wilhelmina Ziekenhuis (CWZ)
Nijmegen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CanisiusWH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.